您的位置: 首页 > 农业专利 > 详情页

4-benzylamino-1-carboxycil-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
专利权人:
Novartis AG
发明人:
Hidetomo Imase,Hongbo Qin,Ichiro Umemura,Kayo Yasoshima,Ken Yamada,Muneto Mogi,Toshio Kawanami,Yuki Iwaki
申请号:
BRPI0819223
公开号:
BRPI0819223A2
申请日:
2008.11.03
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
4-benzylamino-1-carboxycil-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis. the present invention relates to a compound of formula (i): in which variants r1, r2, r3, r4, r5, r6, r7 are defined in this report, and in which said compound is a cetp inhibitor, and therefore, they can be used to treat a disorder or disease mediated by cetp or responsive to cetp inhibition.derivados de 4-benzilamino-1-carboxiacil-piperidina como inibidores de cetp úteis para o tratamento de doenças tais como hiperlipidemia ou arteriosclerose. a presente invenção refere-se a um composto de fórmula (i): em que as variantes r1, r2, r3, r4, r5, r6, r7 são definidas neste relatório, e em que o referido composto é um inibidor de cetp, e portanto podem ser empregados para o tratamento de um distúrbio ou doença mediada por cetp ou responsiva à inibição de cetp.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充